Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan

Chemotherapy

Volumn 58, Issue 1, 2012, Pages 52-59

  Yokota, Shin Ichi ^a   Sato, Toyotaka ^b   Okubo, Torahiko ^b   Ohkoshi, Yasuo ^a   Okabayashi, Tamaki ^a   Kuwahara, Osamu ^c   Tamura, Yutaka ^b   Fujii, Nobuhiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RAKUNO GAKUEN UNIVERSITY   (Japan)

^c Sapporo Clinical Laboratory Inc   (Japan)

Author keywords

Escherichia coli O25:H4; Extended spectrum lactamase; Fluoroquinolone resistance

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; ULIFLOXACIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG POTENCY; ESCHERICHIA COLI; ESCHERICHIA COLI O25 H4; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; FLUOROQUINOLONES; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OFLOXACIN; PREVALENCE; YOUNG ADULT;

EID: 84862804823     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000336129     Document Type: Article

References (29)

1. Schaeffer A: Infections of the urinary tract; in Wein A, Kavoussi L, Novick A, et al (eds): Campbell-Walsh Urology. Philadelphia, Saunders Elsevier, 2007, pp 223-303.
2. Pitout JD, Laupland KB: Extended-spectrum-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 2008; 8: 159-166.
3. Seo M-R, Park YS, Pai H: Characteristics of plasmid-mediated quinolone resistance genes in extended-spectrum cephalosporinresistant isolates of Klebsiella pneumoniae and Escherichia coli in Korea. Chemotherapy 2010; 56: 46-53.
4. Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV: Incidence of fluoroquinolone-resistant and extended-spectrum-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 2011; 57: 335-338.
5. Peirano G, Pitout JD: Molecular epidemiology of Escherichia coli producing CTX-M-lactamases: The worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316-321.
6. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M: Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010; 51: 286-294.
7. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR: Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61: 273-281.
8. Coque TM, Novais A, Carattoli A, Poirel L, Pitout J, Peixe L, Baquero F, Canton R, Nord -mann P: Dissemination of clonally related Escherichia coli strains expressing extendedspectrum-lactamase CTX-M-15. Emerg Infect Dis 2008; 14: 195-200.
9. Coudron PE, Moland ES, Sanders CC: Occurrence and detection of extended-spectrum-lactamases in members of the family Enterobacteriaceae at a veterans medical center: Seek and you may find. J Clin Microbiol 1997; 35: 2593-2597.
10. Clinical and Laboratory Standards Institute: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, ed 8. CLSI document M07-A8. Wayne, Clinical and Laboratory Standards Institute, 2009.
11. Matera MG: Pharmacologic characteristics of prulifloxacin. Pulm Pharmacol Ther 2006; 19(suppl 1):20-29.
12. Yamaguchi K, Ohno A, Ishii Y, Tateda K, Iwata M, The Levofloxacin- Surveillance Group: In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007 (in Japanese). Jpn J Antibiot 2009; 62: 346-370.
13. Lee YJ, Cho JK, Kim KS, Tak RB, Kim AR, Kim JW, Im SK, Kim BH: Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken. J Microbiol 2005; 43: 391-397.
14. Yang H, Chen S, White DG, Zhao S, McDermott P, Walker R, Meng J: Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China. J Clin Microbiol 2004; 42: 3483-3489.
15. Sorlozano A, Gutierrez J, Jimenez A, de Dios Luna J, Martinez JL: Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-lactamase-producing Escherichia coli isolates. J Clin Microbiol 2007; 45: 2740-2742.
16. Takahashi A, Kanamaru S, Kurazono H, Kunishima Y, Tsukamoto T, Ogawa O, Yamamoto S: Escherichia coli isolates associated with uncomplicated and complicated cystitis and asymptomatic bacteriuria possess similar phylogenies, virulence genes, and O-serogroup profiles. J Clin Microbiol 2006; 44: 4589-4592.
17. Takahashi A, Muratani T, Yasuda M, Takahashi S, Monden K, Ishikawa K, Kiyota H, Arakawa S, Matsumoto T, Shima H, Kurazono H, Yamamoto S: Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: Phylogeny, virulence factors, PAI usp subtypes, and mutation patterns. J Clin Microbiol 2009; 47: 791-795.
18. Clermont O, Bonacorsi S, Bingen E: Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
19. Kanamaru S, Kurazono H, Nakano M, Terai A, Ogawa O, Yamamoto S: Subtyping of uropathogenic Escherichia coli according to the pathogenicity island encoding uropathogenic-specific protein: Comparison with phylogenetic groups. Int J Urol 2006; 13: 754-760.
20. Yagi T, Kurokawa H, Shibata N, Shibayama K, Arakawa Y: A preliminary survey of extended-spectrum-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol Lett 2000; 184: 53-56.
21. Shibata N, Kurokawa H, Doi Y, Yagi T, Yamane K, Wachino J, Suzuki S, Kimura K, Ishikawa S, Kato H, Ozawa Y, Shibayama K, Kai K, Konda T, Arakawa Y: PCR classification of CTX-M-type-lactamase genes identified in clinically isolated gram-negative bacilli in Japan. Antimicrob Agents Chemo -ther 2006; 50: 791-795.
22. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y: Change in the prevalence of extended-spectrum-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009; 63: 72-79.
23. Tartof SY, Solberg OD, Manges AR, Riley LW: Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005; 43: 5860-5864.
24. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, Karch H, Reeves PR, Maiden MC, Ochman H, Achtman M: Sex and virulence in Escherichia coli: An evolutionary perspective. Mol Microbiol 2006; 60: 1136-1151.
25. Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C, Denamur E, Arlet G: The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 2008; 61: 1024-1028.
26. Beutin L, Strauch E, Zimmermann S, Kaulfuss S, Schaudinn C, Mannel A, Gelderblom HR: Genetical and functional investigation of fliC genes encoding flagellar serotype H4 in wildtype strains of Escherichia coli and in a laboratory E. coli K-12 strain expressing flagellar antigen type H48. BMC Microbiol 2005; 5: 4.
27. National Molecular Subtyping Network for Foodborne Diseases Surveillance: One-day (24-48 h) standardized laboratory protocol for molecular subtyping of Escherichia coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed field gel electrophoresis (PFGE). Atlanta, Ga., Pulse-Net USA, Centers for Disease Control and Prevention, 2004, pp 1-12.
28. Kawamura-Sato K, Yoshida R, Shibayama K, Ohta M: Virulence genes, quinolone and fluoroquinolone resistance, and phylogenetic background of uropathogenic Escherichia coli strains isolated in Japan. Jpn J Infect Dis 2010; 63: 113-115.
29. Piatti G, Mannini A, Balistreri M, Schito AM: Virulence factors in urinary E scherichia coli strains: Phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 2008; 46: 480-487.